•NRx Pharmaceuticals announced advancements in robotic-enabled Transcranial Magnetic Stimulation (TMS) combined with neuroplastic therapy for military and first responder use.
•The initiative is led by Dr. Dennis K. McBride, a retired Captain of the US Navy Medical Service Corps.
•TG Therapeutics announced the completion of enrollment in a Phase 3 trial evaluating subcutaneous BRIUMVI for relapsing forms of multiple sclerosis (RMS).
•Top-line data from the trial is expected by year-end 2026 or the first quarter of 2027.
•Currently approved BRIUMVI is administered as a one-hour intravenous (IV) infusion twice a year.
•Juniper Group, part of Vela Software (a Constellation Software operating group), entered into a definitive agreement to acquire a majority interest in Derbysoft Holdings Limited.
•Derbysoft Holdings Limited is the ultimate parent company of DerbySoft Inc., a global provider of hotel distribution services.
•Diversified announced a strategic collaboration with Comcast Technology Solutions to support the expansion of CTS's new global Broadcast Operations Center in Colorado.
•The initiative aims to build an advanced, fully IP-based infrastructure to support modern content delivery across broadcast, streaming, and live sports.